Australia’s CSL Invited To Meet With U.S. FDA Over Production Standards
This article was originally published in PharmAsia News
Executive SummaryCSL of Australia has received a request from U.S. FDA to meet with senior officials of its Biotherapies unit to discuss conditions at its vaccine-production plant in the Australian state of Victoria
You may also be interested in...
Genomic profiling firm Foundation Medicine hires new chief commercial officer; Bardy Diagnostics, developer of cardiac arrhythmia devices, picks a chief operating officer; Lantheus Medical Imaging, producer of diagnostic imaging agents and products; brings aboard a new chief medical officer; and more.